Status:
UNKNOWN
Symptomatic Therapy for Patients With Huntington's Disease
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Huntington Disease
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Based on the previous symptomatic treatment of Chinese HD patients, this study intends to further optimize the treatment regimen of Chinese HD patients so as to further improve the prognosis of patien...
Detailed Description
The purpose of the study is to evaluate symptomatic treatment regimen efficacy based on different disease stages. We previously used symptomatic treatment on Chinese HD patients and most of them got i...
Eligibility Criteria
Inclusion
- Genetic diagnosis of Huntington's disease
- Symptomatic patients with Huntington's disease
- Disease duration less than 5 years -
Exclusion
- (1) Movement disorder due to other definite causes instead of Huntington's disease (2) Severe Lung, kidney or liver disease (3) Neoplastic Disease
- \-
Key Trial Info
Start Date :
March 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04071639
Start Date
March 12 2020
End Date
December 31 2024
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009